Medistill
Get StartedConnect to ClaudeSign In

symplr vs Verisys vs Medistill

symplr is an enterprise workforce-and-credentialing suite assembled through 20+ acquisitions. Verisys is a focused primary-source credentialing CVO. Medistill is a 130+ source healthcare intelligence platform at from $199/mo. Three different problems, three different price points. Head-to-head below.

Head-to-head comparison

FeaturesymplrVerisysMedistill
Company focusEnterprise workforce + credentialing + payer enrollment suitePrimary-source credentialing CVO with verification accuracy as the headlineHealthcare intelligence platform: 130+ source compliance, license verification, court records, billing intelligence, industry payments — in one product
Founded2006 (Houston, TX). Built through 20+ acquisitions including HealthcareSource, Halogen, Cactus, Morrisey, IntelliCentrics.1992 (Provo, UT). Pure-play healthcare credentialing and exclusion monitoring.Built by healthcare data engineers and clinicians. Single platform, no acquisitions.
Compliance sources monitored~15-25, depends on module tier~20, focused on primary-source verification130+ sources — every state medical board, every state Medicaid exclusion list, FDA debarment + CLIIL, DEA, federal court records
State medical boardsVaries by contract tierVerified at primary source on demandAll 50 boards, continuously monitored
OIG LEIE / SAM.gov / state Medicaid exclusionsYes, in compliance moduleYes, with continuous monitoringYes, plus all 40 state Medicaid exclusion lists + state Medicare opt-out, continuously monitored
Primary-source verification (PSV)Yes, via Cactus / Morrisey modulesCore product, claimed >99.95% accuracyReal-time license verification; relies on your existing CVO for committee evidence file
Workforce managementYes, scheduling, timekeeping, staffingNot offeredNot offered (intelligence layer, not workflow)
Payer enrollmentYes, automated payer enrollment workflowNot offeredNot offered
Learning management (LMS)Yes, for staff training and complianceNot offeredNot offered
FDA enforcement (debarment, CLIIL)Not coveredNot coveredYes — 156 debarred individuals + 232 disqualified clinical investigators
Industry payments / financial conflictsNot coveredNot coveredYes — 12M+ pharma payment records, conflict detection by NPI
Court records (FCA, qui tam, DEA)Not coveredNot coveredYes — 10M+ federal and state court opinions, full-text searchable
Predictive risk scoringPass/fail or basic flagsPass/fail with severity tiersML risk score 0-100 with A-F grade, per provider
Setup timeWeeks of implementation per moduleDays to weeks for full rollout2 minutes, no implementation
Pricing$75K-$300K+/yr depending on modules$50K-$200K/yr depending on volumefrom $199/mo, no annual contract, no setup fees
Best fitLarge health systems wanting one vendor for workforce + credentialing + payer enrollmentOrganizations where primary-source verification accuracy is the priority and they have their own workforce systemsCompliance teams wanting deeper intelligence than enforcement-only screening, at platform price, ready in minutes

Which one to pick

Pick symplr if:

  • You want one vendor across workforce management, credentialing, payer enrollment, and contract management
  • You have a large enterprise budget ($150K+/yr) and want consolidated vendor management
  • Your team is already on Cactus, Morrisey, or other symplr-acquired products
  • You need pre-built integrations across major EHRs and existing HRIS systems

Pick Verisys if:

  • Primary-source verification accuracy is the single most important factor
  • You're a CVO or operating a credentialing function that needs PSV evidence per provider
  • You already have workforce and payer enrollment handled elsewhere
  • You need NCQA-certified CVO with documented accuracy metrics

Pick Medistill if:

  • You want intelligence beyond pass/fail compliance — billing outliers, financial conflicts, federal court history per NPI
  • You can keep your existing CVO workflow and need a deeper screening + risk layer behind it
  • You want broader source coverage (130+ vs. 15-25) without enterprise pricing or implementation
  • You want to start in 2 minutes at from $199/mo with no annual contract

What both symplr and Verisys miss

Both vendors monitor 15-25 enforcement sources. Both stop at the credentialing layer. Neither tells you whether a provider's billing is an outlier, whether they take pharma payments from companies whose drugs they prescribe, or whether they've been named in federal court litigation. That intelligence layer is where Medistill sits.

  • +All 50 state medical board licensure and discipline records (60 board checks per screen)
  • +All 40 state Medicaid exclusion lists, continuously monitored
  • +FDA Debarment List (156 individuals) and Clinical Investigator Disqualification (232 investigators)
  • +DEA registration and revocation records
  • +Court records: False Claims Act, qui tam, federal enforcement
  • +industry payments (12M+ records) for financial conflict detection
  • +medical-benefit billing patterns and peer benchmarking
  • +Predictive ML risk scoring (0-100 with A-F grade)
  • +10M+ court cases with full opinion text
  • +Batch screening: 500 providers in ~10 minutes
  • +Natural-language queries on desktop and mobile
  • +API for automation, scheduled monitoring, custom reports

Medistill checks 130+ sources for from $199/mo, no annual contract, no implementation. It does not replace symplr's workforce management or Verisys's primary-source verification evidence. It does replace the enforcement screening, license verification, and risk scoring inside both products, with more sources and better intelligence.

symplr vs Verisys, common questions

Should I pick symplr or Verisys for healthcare credentialing?

Pick symplr if you want one enterprise vendor across workforce management, credentialing, payer enrollment, and contract management, and your budget supports $150K to $300K+ per year. Pick Verisys if primary-source verification accuracy is the single most important factor, you operate a CVO function, and you already have workforce and payer enrollment handled elsewhere. symplr is built around module breadth; Verisys is built around verification accuracy.

What is the main difference between symplr and Verisys?

symplr is an enterprise workforce-and-credentialing suite assembled through 20+ acquisitions including Cactus, Morrisey, and IntelliCentrics. It spans scheduling, timekeeping, talent acquisition, payer enrollment, and credentialing modules. Verisys is a focused primary-source credentialing CVO with documented >99.95% verification accuracy. symplr is broad; Verisys is deep on credentialing.

How many compliance sources do symplr and Verisys check?

symplr checks approximately 15 to 25 enforcement sources depending on the module tier. Verisys checks roughly 20 sources focused on primary-source verification. Both include OIG LEIE, SAM.gov, and state Medicaid exclusions. Neither covers FDA debarment, FDA Clinical Investigator Disqualification, federal court records, industry payments, or predictive risk scoring. Medistill covers 130+ sources at from $199 per month.

What does symplr cost compared to Verisys?

symplr typically costs $75,000 to $300,000+ per year depending on which modules a customer licenses. Verisys typically costs $50,000 to $200,000 per year depending on volume. Both require annual contracts and multi-week implementation. Medistill is from $199 per month, no annual contract, and is operational in two minutes.

Can Medistill replace both symplr and Verisys?

Medistill replaces the compliance screening, license verification, and risk scoring inside both products, with more sources (130+) and richer intelligence. Medistill does not replace symplr's workforce management or payer enrollment workflow, and does not replace Verisys's primary-source verification evidence file. Most organizations use Medistill for compliance intelligence and keep their existing credentialing workflow vendor for application routing and committee management.

Pricing

Start free with 50 credits

Pro $199 / 500 credits · Business $499 / 1,500 credits · Unlimited $999 ($9,990/yr) · Team from $599/seat

Full access to all 2,000+ datasets. No per-query fees. 1 credit per entity processed.

All 2,000+ datasets + 10M+ court cases
Natural language AI search
Compliance screening (150+ sources)
Predictive risk scoring
Weekly data refresh
Unlimited credits on Unlimited / Team
Start free, 50 credits

No credit card required. Expires in 15 days.

× No demo required× No sales call× No annual contract on paid tiers× Cancel anytime